Russian Ice Hockey Federation to wage ruthless war on doping abuseSport July 26, 19:53
Two Siberian residents jailed for killing three zoo birds in failed barbeque attemptSociety & Culture July 26, 18:43
Moscow slams Western media allegations about alleged Russian support for TalibanRussian Politics & Diplomacy July 26, 18:31
Ex-Georgian president Saakashvili stripped of Ukrainian citizenshipWorld July 26, 18:25
Russia bolsters military potential in South to respond to emerging threats — defense chiefMilitary & Defense July 26, 16:09
Moscow to frame stance on new sanctions once US bill becomes lawRussian Politics & Diplomacy July 26, 16:03
Kazakhstan hopes to develop its own module for joint space station with RussiaScience & Space July 26, 15:34
EU diplomats move to slap more sanctions on Russia over Siemens turbines furorBusiness & Economy July 26, 15:11
London court binds Ukraine to pay par value of Eurobonds to RussiaBusiness & Economy July 26, 15:05
MOSCOW, April 19. /TASS/. Russian microbiologists discovered a substitution for medial preparation meldonium, which was listed by the World Anti-Doping Agency (WADA) since the beginning of last year as a banned performance enhancing drug, Russian Federal Micro-Biological Agency (FMBA) Head Vladimir Uiba said on Wednesday.
"We have found a substitution for meldonium," Uiba said. "This is a set of medications, which are not included in the list of the banned substances and they are by far effective compared with meldonium."
The drug meldonium (mildronate) was included in the list of preparations banned by the World Anti-Doping Agency from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
Following numerous positive doping tests for meldonium since the beginning of 2016, WADA announced in April last year that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, 2016, was acceptable and the athlete at the issue was not a subject to any sanctions whatsoever.
Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.
The Latvian pharmaceutical firm Grindex, the producer of mildronate, announced in April of 2016 that it sent WADA an overview of the preparation’s use over the past 30 years.
Grindex said in its letter that it decided to send its overview to WADA because the world anti-doping body had not provided the company with sufficient scientific proofs substantiating the inclusion of meldonium into the list of the banned substances. Grindex maintains that meldonium never influenced athletes’ achievements.